16.47USD+1.60%Mkt Cap: 561.52M $P/E: —1d ago
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap561.52M $
Enterprise Value569.14M $
Revenue (TTM)99.53M $
Gross Profit77.22M $
Net Income (TTM)-21.46M $
Revenue/Share2.991 USD
Last Price16.47 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees220
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-55.41
PEG—
EV/EBITDA-34.47
EV/Revenue5.72
P/S5.64
P/B38.66
EPS (TTM)-0.65
EPS (Forward)-0.30
52W Range
7.56374% of range19.60
52W High19.60 USD
52W Low7.563 USD
Profitability
Gross Margin77.23%
Oper. Margin-25.23%
EBITDA Margin-16.59%
Profit Margin-21.47%
ROE-112.79%
ROA-20.33%
Growth
Revenue Growth-2.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.01M $
CapEx (TTM)332.00K $
FCF Margin-2.75%
FCF Yield-0.49%
Net Debt16.48M $
Net Debt/EBITDA-1.00
Balance Sheet
Debt/Equity3.72
Current Ratio5.38
Quick Ratio4.25
Book Value/Sh0.4260 USD
Cash/Share1.583 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)20.00 USD
Upside (mean)+21.4%
Target Range18.00 USD – 22.00 USD
$18.00+21.4% to mean$22.00
# Analysts8
Ownership
Shares Out.34.09M
Float23.29M
Insiders4.04%
Institutions96.28%
Short Interest
Short Ratio4.9d
Short % Float3.04%
Short % Out.2.64%
Shares Short898.59K
Short (prev mo.)582.94K
Technical
SMA 5016.35 (+0.7%)
SMA 20014.83 (+11.0%)
Beta1.89
S&P 52W Chg20.25%
Avg Vol (30d)158.68K
Avg Vol (10d)154.37K
Technical Indicators
RSI (14)51.1
MACD0.1423
MACD Signal0.1515
MACD Hist.-0.0092
BB Upper17.74 USD
BB Middle16.27 USD
BB Lower14.80 USD
BB Width18.09%
ATR (14)0.8801 USD
Vol Ratio (20d)0.40x